en

PRODUCT DETAIL

Saphnelo 300 mg koncentrát na infúzny roztok

Code 9744D
MA number EU/1/21/1623/001
Product Form: con inf 1x2 ml/300 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AA Selective immunosuppressants
L04AA51 Anifrolumab
Shelf life: 36
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 14.02.2022
Validity: 14.02.2027
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 25.02.2022
eu-flag.png sk-flag.png